
2 minute read
9. d) Syria
from 79th Session of the Executive Committee of the European Commission for the Control of Foot-and-Mouth
by EuFMD
table for actions. Further, where training is involved this commitment must be there to use the trainees to continue within the project to achieve agreed objectives. Regarding Phase III, the mission team reviewed the five components proposed by the IVO, and identified activities where external inputs could be critical to progress at national level. These components were mainly in technical guidance in FMD monitoring and surveillance (components 1,3 4) and laboratory support to FMD monitoring (incidence, rapid FMDV typing, and vaccination monitoring; Component 2). The IVO had requested support to establish a Control Zone in Western Iran, which could be a major success if it achieved progress to reduce impact of transboundary animal movements; inputs here would be to support regional meetings and guide local investigation/planning of control measures. Component 5, on animal ID and movement control systems, could be assisted through technical guidance (consultancy to design I&R systems). Overall the objectives identified by Iran were high, and therefore national commitment obtained would achieve significant progress. Regarding the next Steps, Dr Geiger indicated that the Iranian authorities were reconsidering the need for external assistance for Phase III objectives identified in 2009, there being caution in developing new projects with external agencies. Based on their recommendations, they would formulate a revised Draft of Phase III and send to the EuFMD Commission, and if agreed by EuFMD/EC, this could proceed to signature of a new MoU (agreement). Discussion The Chairman thanked Dr Geiger for his work in leading the review team and for the clear summary of issues to be addressed. Concerns were expressed to ensure lessons were leant from the recent Phase, particularly to ensure the objectives for Phase III are achievable, with a clear commitment of the parties to local project management system and that external training or inputs are possible under the current circumstances. Dr Domenech, France, indicated their strong interest to see a Phase III in order to maintain links and knowledge of situation in a difficult country. In conclusion, the Committee - Reaffirmed the importance to Turkey, the EC and EuFMD for continued activity to develop and agree with the IVO the way forward and type of support that will be most effective; - agreed that a Phase III proposal should be, if possible, approved by the ExCom in May 2010 for decision/finalisation with the EC. decide /finalise/with EC. It was agreed that France would organize, at the time of the OIE May2010 Session, a meeting place for the ExCom to meet separately and together with Iranian authorities to agree upon the way forward with Phase III. 9. d) Syria
Background Support to FMD surveillance in Syria was agreed between EuFMD/EC in 2008 and a small project implemented that focussed on design of a monitoring system and laboratory capacity for serosurveillance. Situation FMD has not been reported in Syria since 2002, an apparent anomaly given that all neighbouring countries have had recent epidemics of A Iran 05 or type O. Progress of the project was summarised by Dr Ben Youssef (Appendix 20), following his joint mission with Dr Potzsch in February 2010. Progress to implement agreed surveillance plan had been slow, but results (for LR) provided during the mission, all 5000 sera had negative results, a surprising finding. A timetable for follow-up actions
Advertisement